SEC 13F Intelligence

Difesa Capital Management, LP / BMRN

Difesa Capital Management, LP’s Biomarin Pharmaceutical Inc Position

Does Difesa Capital Management, LP own Biomarin Pharmaceutical Inc (BMRN)? Not currently — the last reported position was 9.3K shares worth $801,790 in Q2 2023; the fund’s latest 13F (Q4 2023) no longer reports it.

Position Value
$801,790
Q2 2023
Shares
9.3K
% of Portfolio
+2.11%
Quarters Held
5
position exited

Position History BMRN

Reported value by quarter
Q2 ’22: $228,000Q2 ’22Q3 ’22: $254,000Q3 ’22Q4 ’22: $1MQ4 ’22Q1 ’23: $1MQ1 ’23Q2 ’23: $801,790Q2 ’23filingsflow.com
QuarterSharesValue% of Portfolio
Q2 20239.3K$801,790+2.11%
Q1 202311.4K$1M+0.73%
Q4 202211.0K$1M+0.88%
Q3 20223.0K$254,000+0.13%
Q2 20222.8K$228,000+0.13%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Difesa Capital Management, LP’s full portfolio or all institutional holders of BMRN.